Physician profile
David L Brown
NPI 1821080193
$1,068.45
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $294 · 2021: $302 · 2022: $102 · 2023: $54.15 · 2024: $13.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $67.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $67.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $362.90 | 2019-2023 | Amplatzer Talisman |
| Inari Medical, INC. | $146.16 | 2020 | |
| Amgen INC. | $98.11 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $94.05 | 2019-2022 | |
| Medtronic Vascular, INC. | $61.60 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.11 | 2019-2022 | |
| Medtronic, INC. | $45.85 | 2021-2024 | Abre |
| Chiesi USA, INC. | $35.39 | 2021-2022 | |
| Amarin Pharma, INC. | $30.66 | 2020-2021 | |
| Pfizer INC. | $25.96 | 2019 | |
| Novartis Pharmaceuticals Corporation | $21.05 | 2019 | |
| Cardinal Health 200 LLC | $20.58 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $17.56 | 2021 | |
| Phathom Pharmaceuticals, INC. | $17.41 | 2023 | Voquezna |
| Teleflex LLC | $16.47 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.04 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.